Managers / Q1 2020 · view latest →
M.D. Sass, LLC
CIK 0000922940 · 55 WEST 46TH STREET, SUITE 2801, NEW YORK, NY, 10036 · 2127302000
Reported Value
$275M
Q1 2020
Positions
60
Filings on Record
37
2019–present window
Filed
May 6, 2020
original filing
Summary
M.D. Sass, Llc reported $275M in U.S.-listed holdings across 60 positions for Q1 2020.
Its largest position, CCK, represents 5.2% of the portfolio.
Compared with Q4 2019, the fund opened 26 new positions and exited 31.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.3B | 36 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.3B | 35 | Feb 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.2B | 35 | Nov 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 35 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.1B | 32 | May 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.3B | 34 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.4B | 36 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.4B | 33 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $887M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $832M | 31 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $744M | 32 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $754M | 30 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $802M | 33 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $680.5B | 46 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $545M | 51 | Nov 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $529M | 49 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $584M | 50 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $644M | 53 | Feb 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $588M | 55 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $605M | 58 | Aug 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $568M | 59 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $467M | 55 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $377M | 58 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $275M | 60 | May 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $859M | 100 | Jan 30, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2019 | $424M | 92 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $432M | 108 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $628M | 108 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $589M | 105 | Feb 11, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- M.D. Sass Associates, Inc.028-12005
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.